Cognition Disorders (Latest Articles)

Latest indexed articles for 'Cognition Disorders'

Articles 1 to 10 of 200:

Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis.

13 Dec 2009 BACKGROUND: Progressive neurodegeneration may result in potentially severe cognitive and motor dysfunctions as a complication of Langerhans cell histiocytosis (LCH), a suggested IL-17A-associated inflammatory condition. To detect this complication ...
rec_pub_19688833-biomarkers-cerebrospinal-fluid-neurodegeneration-langerhans-cell.htm

Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up.

29 Nov 2009 BACKGROUND: Kinsbourne syndrome or opsoclonus myoclonus syndrome (OMS) is characterized by rapid, involuntary, irregular conjugate eye movements (opsoclonus), myoclonic jerking of the limbs and trunk, ataxia, and behavioral disturbances. In general, ...
rec_pub_19672966-improvement-neurological-status-quality-life-children-opsoclonus.htm

Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("Ecstasy") users.

2 Nov 2009 Methylenedioxymethamphetamine (MDMA; "Ecstasy") is a popular recreational drug and brain serotonin (5-HT) neurotoxin. Neuroimaging data indicate that some human MDMA users develop persistent deficits in brain 5-HT neuronal markers. Although the ...
rec_pub_19890014-sleep-deprivation-differentially-impairs-cognitive-performance.htm

Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI study.

Nov 2009
rec_pub_19884585-postmenopausal-hormone-therapy-regional-brain-volumes-whims-mri-study.htm

Donepezil treatment of patients with MCI: a 48-week randomized, placebo- controlled trial.

Nov 2009
rec_pub_19884584-donepezil-treatment-patients-mci-48-week-randomized-placebo.htm

Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort.

Nov 2009 OBJECTIVE: To investigate the incidence of and risk factors for cognitive impairment in a large, well-defined clinical trial cohort of patients with early Parkinson disease (PD). METHODS: The Mini-Mental State Examination (MMSE) was administered ...
rec_pub_19884574-incidence-risk-factors-cognitive-impairment-early-parkinson-disease.htm

Subcortical vascular versus amnestic mild cognitive impairment: comparison of cerebral glucose metabolism.

Nov 2009 BACKGROUND AND PURPOSE: Most studies on mild cognitive impairment (MCI) have been focused on amnestic MCI (aMCI) that is the preclinical stage of Alzheimer's disease (AD). In contrast, only a few studies have involved patients in the preclinical ...
rec_pub_19021838-subcortical-vascular-versus-amnestic-mild-cognitive-impairment.htm

Using a Socratic dialogue to tackle thorny issues of psychiatry.

30 Oct 2009 Medical students often experience significant cognitive dissonance as they attempt to understand psychiatry. After the security of lab values and medical tests that characterize much of medical practice, the ambiguity of seemingly subjectively ...
rec_pub_19858818-using-socratic-dialogue-tackle-thorny-issues-psychiatry.htm

Prevalence of dementia and cognitive impairment in Southeastern Spain: the Ariadna study.

30 Oct 2009 OBJECTIVES: To estimate the prevalence of amnestic mild cognitive impairment (aMCI), cognitive impairment, no dementia (CIND) and dementia in a general elderly population and to examine the associated socio-demographic factors. METHODS: The Ariadna ...
rec_pub_19832772-prevalence-dementia-cognitive-impairment-southeastern-spain-ariadna.htm

Invited commentary.

30 Oct 2009
rec_pub_19853086-invited-commentary.htm

Results: [1-10] [11-20] [21-30] [31-40] [41-50] [51-60] [61-70] [71-80] [81-90] [91-100] [101-110] [111-120] [121-130] [131-140] [141-150] [151-160] [161-170] [171-180] [181-190] [191-200]